Resource Type

Journal Article 3

Year

2023 2

2007 1

Keywords

Hyperlipidemia 2

16-week treatment 1

Bifidobacterium longum 1

Bile acid (BA) 1

Cardiovascular and cerebrovascular diseases 1

Chinese herbal medicines 1

Fecal metabolites 1

Gut microbiota 1

Hyperglycemia 1

NO 1

Probiotics 1

endothelial 1

leukocyte accumulation 1

mg/kg 1

open ︾

Search scope:

排序： Display mode:

Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate

WU Jun, LIN Jinchao, HE Zhaochu, OU Biru, GUO Haisen

Frontiers of Medicine 2007, Volume 1, Issue 4,   Pages 356-358 doi: 10.1007/s11684-007-0068-5

Abstract: The effect of hyperlipidemia and inflammation on endothelial functions was studied.The enrolled included control (basic chow), hyperlipidemia and fenofibrate-treated groups (high fat dietThe hyperlipidemia model was set up by four-week atherogenic diet, followed by a 16-week treatment inthe fenofibrate-treated group (fenofibrate 40 mg/kg every day) and without treatment in the hyperlipidemiaHyperlipidemia can inhibit the NO activity and promote the damage of VACA-1 to aortic endothelia.

Keywords： endothelial     16-week treatment     leukocyte accumulation     mg/kg     NO    

HTML PDF Collect

Bioactive Components of Chinese Herbal Medicines in the Treatment of Glucose and Lipid Metabolism Disorders: Evidence and Potential Mechanisms Review

Ying Zhang, Jiaming Ju, Lei Jiao, Baofeng Yang

Engineering 2023, Volume 29, Issue 10,   Pages 73-82 doi: 10.1016/j.eng.2023.03.004

Abstract: treatment of cardiovascular and cerebrovascular diseases, with the advantages of preventing and curing hyperlipidemiaclinical research progress of bioactive components of CHM and their preparations as therapeutics for hyperlipidemia

Keywords： Chinese herbal medicines     Hyperlipidemia     Hyperglycemia     Cardiovascular and cerebrovascular diseases    

HTML PDF Collect

Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition Article

Chuanqi Chu, Jinchi Jiang, Leilei Yu, Yiwen Li, Songli Zhang, Wei Zhou, Qun Wang, Jianxin Zhao, Qixiao Zhai, Fengwei Tian, Wei Chen

Engineering 2023, Volume 28, Issue 9,   Pages 193-205 doi: 10.1016/j.eng.2023.04.010

Abstract: of studies have indicated that gut microbiota and its metabolites are crucial in the development of hyperlipidemiaevaluate the potential of B. longum CCFM1077 in lowering the lipid levels in patients with hyperlipidemiaSubjects with hyperlipidemia (N = 62) were randomly assigned to receive placebo (NCCFM1077 is a probiotic strain with the potential to lower serum TC and LDL-C levels patients with hyperlipidemiafoundation for future clinical applications of lipid-lowering probiotics in managing individuals with hyperlipidemia

Keywords： Probiotics     Bifidobacterium longum     Hyperlipidemia     Gut microbiota     Fecal metabolites     Bile acid    

HTML PDF Collect

Title Author Date Type Operation

Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate

WU Jun, LIN Jinchao, HE Zhaochu, OU Biru, GUO Haisen

Journal Article

Bioactive Components of Chinese Herbal Medicines in the Treatment of Glucose and Lipid Metabolism Disorders: Evidence and Potential Mechanisms

Ying Zhang, Jiaming Ju, Lei Jiao, Baofeng Yang

Journal Article

Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition

Chuanqi Chu, Jinchi Jiang, Leilei Yu, Yiwen Li, Songli Zhang, Wei Zhou, Qun Wang, Jianxin Zhao, Qixiao Zhai, Fengwei Tian, Wei Chen

Journal Article